Activation of HERV-K(HML-2) Disrupts Cortical Patterning and Neuronal Differentiation by Increasing NTRK3
Overview
Authors
Affiliations
The biological function and disease association of human endogenous retroviruses (HERVs) are largely elusive. HERV-K(HML-2) has been associated with neurotoxicity, but there is no clear understanding of its role or mechanistic basis. We addressed the physiological functions of HERV-K(HML-2) in neuronal differentiation using CRISPR engineering to activate or repress its expression levels in a human-pluripotent-stem-cell-based system. We found that elevated HERV-K(HML-2) transcription is detrimental for the development and function of cortical neurons. These effects are cell-type-specific, as dopaminergic neurons are unaffected. Moreover, high HERV-K(HML-2) transcription alters cortical layer formation in forebrain organoids. HERV-K(HML-2) transcriptional activation leads to hyperactivation of NTRK3 expression and other neurodegeneration-related genes. Direct activation of NTRK3 phenotypically resembles HERV-K(HML-2) induction, and reducing NTRK3 levels in context of HERV-K(HML-2) induction restores cortical neuron differentiation. Hence, these findings unravel a cell-type-specific role for HERV-K(HML-2) in cortical neuron development.
Retrotransposon: a versatile player in human preimplantation development and health.
Qu Y, Izsvak Z, Wang J Life Med. 2025; 2(1):lnac041.
PMID: 39872950 PMC: 11748968. DOI: 10.1093/lifemedi/lnac041.
Bo M, Carta A, Cipriani C, Cavassa V, Simula E, Huyen N Microorganisms. 2025; 13(1).
PMID: 39858776 PMC: 11767913. DOI: 10.3390/microorganisms13010009.
Tschuck J, Padmanabhan Nair V, Galhoz A, Zaratiegui C, Tai H, Ciceri G Nat Commun. 2024; 15(1):7611.
PMID: 39218970 PMC: 11366759. DOI: 10.1038/s41467-024-51996-1.
Tavakolian S, Goudarzi H, Faghihloo E J Res Med Sci. 2024; 29:20.
PMID: 38855560 PMC: 11162086. DOI: 10.4103/jrms.jrms_141_23.
Antiretroviral Drug Repositioning for Glioblastoma.
Rivas S, Valdez M, Chandar J, Desgraves J, Lu V, Ampie L Cancers (Basel). 2024; 16(9).
PMID: 38730705 PMC: 11083594. DOI: 10.3390/cancers16091754.